Cargando…
Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
BACKGROUND AND OBJECTIVE: For patients with advanced colorectal liver metastases (CRLMs) receiving first-line anti-angiogenic therapy, an accurate, rapid and noninvasive indicator is urgently needed to predict its efficacy. In previous studies, dynamic radiomics predicted more accurately than conven...
Autores principales: | Qu, Hui, Zhai, Huan, Zhang, Shuairan, Chen, Wenjuan, Zhong, Hongshan, Cui, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939899/ https://www.ncbi.nlm.nih.gov/pubmed/36814812 http://dx.doi.org/10.3389/fonc.2023.992096 |
Ejemplares similares
-
A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents
por: Chen, Jianan, et al.
Publicado: (2023) -
Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022) -
Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis
por: Li, Yue, et al.
Publicado: (2022) -
Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023) -
Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis
por: Wang, Yun, et al.
Publicado: (2022)